TCTMD

Implantation of Boston Scientific COGNIS™Cardiac Resynchronization Therapy Defibrillator (CRT-D) Begins in China

Shanghai, China - The first patient implants of the Boston Scientific Corporation COGNIS™ cardiac resynchronization therapy defibrillator (CRT-D) were successfully performed in China’s Zhejiang ...
Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
TCTMD

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...
MassDevice

Biotronik study backs 2-lead defibrillation system

Results from the multi-center CRT-NEXT study demonstrated that CRT-DX is as safe and effective as conventional three-lead CRT ...
Medscape

Cardiac Resynchronization Therapy for the Treatment of Heart Failure

6MWD: 6-min walk distance; CARE-HF: Cardiac Resynchronization-Heart Failure; COMPANION: Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure; CRT-D: Cardiac resynchronization ...
EurekAlert!

Patients who need cardiac resynchronization therapy may be eligible for Cedars-Sinai clinical trials

LOS ANGELES (March 8, 2002) – Patients who suffer from advanced congestive heart failure and heart rhythm abnormalities may qualify to participate in one of two research trials now underway at ...
Nature

Does cardiac resynchronization therapy reduce the long-term mortality risk in patients with heart failure?

Cardiac resynchronization therapy (CRT), with or without a defibrillator, has been shown to improve symptoms, quality of life, and prognosis in patients with moderate-to-severe heart failure (HF) ...
Nature

Cardiac resynchronization therapy or atrio-biventricular pacing—what should it be called?

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...
News Medical

UVA researcher receives Trailblazer R21 Award to improve cardiac resynchronization therapy outcomes

Pacemakers and other implantable devices that restore normal heart rhythms have saved millions of lives. In some patients, a pacemaker or implantable cardioverter defibrillator modified for "cardiac ...
The American Journal of Managed Care

Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy

With increased recognition of the link between cancer care and heart disease, more studies are evaluating the interconnectedness of cancer survival, chemotherapy, and heart failure (HF) in patients ...
Nasdaq

Medtronic Receives CE Mark for Cobalt™ and Crome™ Portfolio of BlueSync™-Enabled Implantable Defibrillators, Cardiac Resynchronization Therapy-Defibrillators

DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable ...